Patrick Burnett, MD, PhD

home / authors / patrick-burnett-md-phd

Patrick Burnett, MD, PhD, is a board-certified dermatologist and the chief medical officer of Arcutis Biotherapeutics.

Articles

Pipeline Updates on the Horizon From Arcutis Biotherapeutics

Kaitlyn Bader, Assistant Managing Editor;Patrick Burnett, MD, PhD

March 6th 2025

Patrick Burnett, MD, PhD, shares key updates expected in 2025 for therapeutics treating atopic dermatitis, alopecia areata, and more.

Patrick Burnett, MD, PhD, Highlights Arcutis’ New Seborrheic Dermatitis Initiative With Odell Beckham Jr.

Kaitlyn Bader, Assistant Managing Editor;Patrick Burnett, MD, PhD

February 17th 2025

The overwhelmingly positive feedback from both clinicians and patients reinforces the unmet need roflumilast foam is addressing in seborrheic dermatitis care.

Latest Updated Articles

Published: September 19th 2024 | Updated: September 26th 2024

Final Thoughts: The Importance of Comparative Studies in AD

Published: March 11th 2025 | Updated: March 31st 2025

Optimizing Laser Therapy for Vascular Anomalies: Why Early Multidisciplinary Care Matters

Published: March 15th 2025 | Updated: March 31st 2025

Apoptosis-Based Skin Cancer Treatment Shows Promise

Published: March 7th 2025 | Updated: March 31st 2025

Tattoo Ink Risks, MultiFrax Laser, and the Impact of GLP-1 Medications on Skin Health

Published: March 8th 2025 | Updated: March 31st 2025

Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD

Published: March 8th 2025 | Updated: March 31st 2025

Late-Breaking Data: Phase 3 Updates on Ruxolitinib Cream for Prurigo Nodularis